Skip to main content
Signal8

Chow Gregory K.

SEC insider (Form 3/4/5 filer). CIK 0001761333. CFO at SUTRO BIOPHARMA, INC. (STRO). 7 reported Form 4/5 transactions since Sep 2024; latest on Jun 2, 2026. Located in SOUTH SAN FRANCISCO, CA.

Companies Chow Gregory K. has filed insider reports for

  • SUTRO BIOPHARMA, INC. (STRO): Officer, CFO
Chow Gregory K. profile photo

Chow Gregory K.

CIK: 0001761333

Transaction Breakdown

Open Market Buys (P)1 (14.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (14.3%)

Derivative conversions

Awards (A)5 (71.4%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

SUTRO BIOPHARMA, INC. logo
STRO

SUTRO BIOPHARMA, INC.

Officer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

  • SUTRO BIOPHARMA, INC. logo
    STRO

    SUTRO BIOPHARMA, INC.

    Jun 2, 2026
    Exercise
    Direct
    2.5K shares-
  • SUTRO BIOPHARMA, INC. logo
    STRO

    SUTRO BIOPHARMA, INC.

    Mar 2, 2026
    Award

    Stock Option (right to buy)

    Direct
    40K shares-
  • SUTRO BIOPHARMA, INC. logo
    STRO

    SUTRO BIOPHARMA, INC.

    Mar 2, 2026
    Award

    Restricted Stock Units (RSUs)

    Direct
    5K shares-
  • SUTRO BIOPHARMA, INC. logo
    STRO

    SUTRO BIOPHARMA, INC.

    Dec 23, 2025
    Award

    Stock Option (right to buy)

    Direct
    8.2K shares-
  • SUTRO BIOPHARMA, INC. logo
    STRO

    SUTRO BIOPHARMA, INC.

    Oct 15, 2025
    Purchase
    Direct
    19.8K shares at avg. $0.81$16K
  • SUTRO BIOPHARMA, INC. logo
    STRO

    SUTRO BIOPHARMA, INC.

    Jun 2, 2025
    Award

    Stock Option (right to buy)

    Direct
    275K shares-
  • SUTRO BIOPHARMA, INC. logo
    STRO

    SUTRO BIOPHARMA, INC.

    Jun 2, 2025
    Award

    Restricted Stock Unit (RSU)

    Direct
    100K shares-

1-7 of 7